Developing Correlates of Protection for Vaccines Is Needed More than Ever—Influenza, COVID-19 and RSV Infection
One of the greatest success stories of modern medicine is the prevention of infectious diseases by vaccination, most notably against smallpox and poliomyelitis. However, recent events, such as the 2009–2010 swine flu and the 2020 COVID-19 pandemics, as well as the continued emergence of highly patho...
Saved in:
| Main Authors: | Zoltan Vajo, Csaba Laszlofy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/16/11/1671 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of mortality and cardiovascular complications due to COVID-19, RSV, and influenza in hospitalized children and young adults
by: Sagya Khanal, et al.
Published: (2024-11-01) -
Durability of Adaptive Immunity in Immunocompetent and Immunocompromised Patients Across Different Respiratory Viruses: RSV, Influenza, and SARS-CoV-2
by: Achilleas Livieratos, et al.
Published: (2024-12-01) -
Protective or limited? Maternal antibodies and RSV-associated lower respiratory tract infection in hospitalized infants aged 28-90 days
by: Shuanglian Li, et al.
Published: (2025-01-01) -
Impact of SARS CoV-2 / Influenza A & B / RSV Multiplex PCR Screening Algorithm on Patient Management and Antimicrobial Use
by: Sultan Gülbahçe Orhan, et al.
Published: (2024-12-01) -
The Development of Animal Models for Respiratory Syncytial Virus (RSV) Infection and Enhanced RSV Disease
by: Gengxin Zhang, et al.
Published: (2024-10-01)